GOLDMAN SACHS GROUP INC - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 36 filers reported holding LUMOS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$1,341,641
-0.1%
406,558
-0.1%
0.00%
Q2 2023$1,342,915
-0.2%
406,944
+0.1%
0.00%
Q1 2023$1,345,677
-20.6%
406,549
-13.4%
0.00%
Q4 2022$1,694,415
-67.2%
469,367
-19.6%
0.00%
-100.0%
Q3 2022$5,167,000
+88.5%
583,896
+64.0%
0.00%0.0%
Q2 2022$2,741,000
-18.1%
355,987
-0.0%
0.00%0.0%
Q1 2022$3,346,000
+35.6%
356,008
+0.0%
0.00%
Q4 2021$2,467,000355,9900.00%
Other shareholders
LUMOS PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 10,175$70,512,0000.26%
Minerva Advisors LLC 34,015$236,0000.14%
Investors Financial Group, LLC 30,600$212,0000.10%
Lion Point Capital, LP 51,205$354,0000.10%
NEA Management Company, LLC 376,916$2,612,0000.05%
Wealth Advisors of Iowa, LLC 11,699$81,0000.04%
Paladin Advisory Group, LLC 4,382$30,0000.02%
Marquette Asset Management, LLC 13,315$92,0000.02%
Blackstone Inc. 468,145$3,244,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$331,0000.01%
View complete list of LUMOS PHARMA INC shareholders